Bristol Myers Squibb (BMY)

Cost of Revenue

$3.73B

Quarterly · Period ending: · USD

BMY logo

BMY Cost of Revenue

Latest reported$3.73B
BMY Quarterly Cost of Revenue ($0.00 → $3.73B)
High-resolution chart · PNG

BMY cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
1,347,000,000
1,283,000,000
1,102,000,000
1,013,000,000
1,200,000,000
954,000,000
1,282,000,000
997,000,000
1,197,000,000
1,138,000,000
1,139,000,000
1,035,000,000
1,060,000,000
997,000,000
997,000,000
970,000,000
962,000,000
944,000,000
927,000,000
877,000,000
839,000,000
804,000,000
732,000,000
843,000,000
823,000,000
791,000,000
790,000,000
678,000,000
662,000,000
665,000,000
730,000,000
687,000,000
639,000,000
665,000,000
498,000,000
748,000,000
677,000,000
639,000,000
708,000,000
648,000,000
660,000,000
668,000,000
696,000,000
660,000,000
636,000,000
638,000,000
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.